PRESENTATION TITLE
Cellular Senescence, Senolytics, Cancer, and Aging

PRESENTER(S)
James L. Kirkland, M.D., Ph.D., Consultant, Division of General Internal Medicine, Department of Internal Medicine, Consultant, Department of Physiology & Biomedical Engineering, Consultant, Section of Geriatric Medicine and Gerontology, Department of Internal Medicine, Professor of Medicine and Physiology, Mayo Clinic, Rochester, Minnesota

PRESENTER BIO

The major research focus of James L. Kirkland, M.D., Ph.D., is the impact of cellular aging (senescence) on age-related dysfunction and chronic diseases, especially developing methods for removing these cells and alleviating their effects. Senescent cells accumulate with aging and in such diseases as dementias, atherosclerosis, cancers, diabetes, and arthritis, even in younger people.

The goal of Dr. Kirkland's current work is to develop methods to remove these cells to delay, prevent, alleviate, or partially reverse age-related chronic diseases as a group and extend health span, the period of life free of disability, pain, dependence, and chronic disease.

Focus areas

• Cellular senescence. Dr. Kirkland's team developed the idea that removing senescent cells may enhance health span, partly based on the observation that mice with mutations that increase life span have a lower senescent cell burden compared with that of normal mice, and that short-lived mice have more of these cells.
• Senolytic drugs. Dr. Kirkland and his team devised a novel strategy to discover the first senolytic drugs, agents that selectively eliminate senescent cells. They uncovered mechanisms that senescent cells use to protect themselves against the factors they release to kill normal cells and damage tissues near them. Dr. Kirkland's team then developed ways to transiently disable these senescent cell protective mechanisms, resulting in senescent cells "committing suicide" instead of killing cells around them. These senolytics are effective in delaying, preventing, alleviating, or treating multiple conditions and diseases in mice. They are currently in clinical trials for serious senescence-related diseases, in which they have shown early signs of promise.
• Diabetes, other chronic diseases, and cellular senescence. Diabetes and obesity are associated with accumulation of senescent cells in fat and other tissues. Dr. Kirkland's group is working on ways to reduce severity and alleviate the complications of diabetes by clearing senescent cells or blocking them from producing factors that cause or exacerbate dysfunction. Effects of eliminating senescent cells or the factors they release are being investigated for frailty, Alzheimer's disease, arthritis, osteoporosis, cancers, and a range of other disorders in Dr. Kirkland's laboratory and with collaborators at Mayo and other institutions.

Significance to patient care

• Dr. Kirkland's work is important in developing methods to enhance health span and delay onset of chronic age-related diseases as a group, rather than one at a time. These conditions, including diabetes, dementias, atherosclerosis, cancers, and arthritis, among others, account for the bulk of morbidity, mortality, and health care costs throughout most of the world.

VIEWING LOCATIONS
Zoom Registration Link

LEARNING OBJECTIVES

• Define cellular senescence.
• Recognize senolytics.
• Construct the route to eventual clinical application of senolytics for cancer.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.